Your browser doesn't support javascript.
loading
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Khalaf, Daniel J; Annala, Matti; Taavitsainen, Sinja; Finch, Daygen L; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Sunderland, Katherine; Azad, Arun A; Kollmannsberger, Christian K; Eigl, Bernhard J; Noonan, Krista; Wadhwa, Deepa; Attwell, Andrew; Keith, Bruce; Ellard, Susan L; Le, Lyly; Gleave, Martin E; Wyatt, Alexander W; Chi, Kim N.
Afiliación
  • Khalaf DJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Annala M; Vancouver Prostate Centre, Vancouver, BC, Canada; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Taavitsainen S; Vancouver Prostate Centre, Vancouver, BC, Canada; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Finch DL; BC Cancer, Kelowna, BC, Canada.
  • Oja C; BC Cancer, Surrey, BC, Canada.
  • Vergidis J; BC Cancer, Victoria, BC, Canada.
  • Zulfiqar M; BC Cancer, Abbotsford, BC, Canada.
  • Sunderland K; Division of Cancer Surveillance and Outcomes, BC Cancer, Vancouver, BC, Canada.
  • Azad AA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kollmannsberger CK; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Eigl BJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Noonan K; BC Cancer, Surrey, BC, Canada.
  • Wadhwa D; BC Cancer, Kelowna, BC, Canada.
  • Attwell A; BC Cancer, Victoria, BC, Canada.
  • Keith B; BC Cancer, Abbotsford, BC, Canada.
  • Ellard SL; BC Cancer, Kelowna, BC, Canada.
  • Le L; BC Cancer, Surrey, BC, Canada.
  • Gleave ME; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Wyatt AW; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Chi KN; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: kchi@bccancer.bc.ca.
Lancet Oncol ; 20(12): 1730-1739, 2019 12.
Article en En | MEDLINE | ID: mdl-31727538
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Canadá